Menu
Products & Markets
Overview
Products & Markets
Products
Enzymes
High-performance Microorganisms
Markets
Nutrition
Health
Environmental
Application
Innovation Examples
Application fields
Solutions
Overview
Solutions
Technology expertise
Enzyme Technology
Microbial Strain Development
Bioprocess Development
BRAIN Bioarchive
Bioactives
Services
Our services
We CRISPR for you
Company
Overview
Company
About BRAIN
BRAIN Biotech Group
BRAIN Biotech AG
Management
Contact
Corporate Culture
Investors
Overview
Investors
Management
BRAIN Biotech at a Glance
Information
Share
Financial News
Publications / Presentations
Financial Highlights
Capital Markets Day
Merger Information
ESG & Sustainability
ESG | Sustainability
Corporate Governance
Compensation
Statement of Conformity
Equity Story
Equity Story & more
FAQs and Glossary
Dates and Events
Annual General Meetings
Financial Calendar
Investors Events
Request Information
Media & News
Overview
Media & News
Information
News & Views
Press Releases
Events
Resources
Press Images
Publications / Presentations
Career
Overview
Career
Work at BRAIN Biotech
Job Advertisements
Start at BRAIN Biotech
Opportunities for University Students
Opportunities for School Students
BRAIN Biotech Network
Alumni
Contact
Search
EN
DE
Contact
Search
EN
DE
Investors
Equity Story & more
Equity Story - Reason 5
Reason 1
Reason 2
Reason 3
Reason 4
Reason 5
Reasons to invest
Reason No. 5: We have embarked on a clear path towards profitable growth
We have been on a clear growth track again for the last two years. We aim to double the Group’s revenue in the medium term while at the same time increasing the adjusted EBITDA margin.
The BioProducts area is the Group’s primary growth segment. We have already invested heavily in expanding production capacity at our sites in recent years.
Our growth strategy is geographically focused on Europe and North America.
We offer highly innovative solutions and products for our customers through the close integration of our biotechnological research and production expertise.
Share this page
Share on Xing
Share on LinkedIn
Share via Email